Skip to main content
CRVLCorVel Corp.Sell5.1·$59.86+1.44%
SellModerate Confidence
Investment thesis

The stock is in a confirmed technical downtrend — trading below its 200-day moving average with a negative slope and falling volume accumulation, with a death-cross pattern in effect — and has missed earnings estimates in all four available reporting periods, making a near-term recovery difficult to justify on the evidence at hand.

Thesis pillars

  • Return On Equity SustainabilityStable
  • Confirmed Price DowntrendStable
  • Earnings Miss StreakStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

CorVel Corp. (CRVL) Stock Analysis

Falling Knife setup

SellVALUE-TRAP 1/5QualityModerate Confidence

Financial Services · Insurance Brokers

Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $59.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Consecutive earnings misses (4); Negative momentum.

CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill review, PPO network management, utilization management, case management, and pharmacy services — nationwide to insurers, TPAs, and self-insured employers.... Read more

$59.86+8.8% A.UpsideScore 5.1/10#14 of 14 Insurance Brokers
QualityF-score8 / 9FCF yield3.04%
Stop $56.74Target $65.14(resistance)A.R:R 0.0:1

Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $59.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Consecutive earnings misses (4); Negative momentum. Chart setup: Death cross, below all MAs, RSI 28, MACD bearish. Score 5.1/10, moderate confidence.

Passes 4/9 gates (clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.

10-K grounded · weekly refresh

About CorVel Corp.

About CorVel Corp.

CorVel Corporation delivers medical cost containment and managed care services for workers' compensation, automobile insurance, and group health claims through a nationwide branch network backed by a primary data center in Portland, Oregon, and a redundancy center in Lone Mountain, Nevada. The proprietary PPO network exceeded 1.2 million providers at March 31, 2026. No single customer accounted for 10% or more of revenue in fiscal years 2026, 2025, or 2024, with clients spanning insurers, TPAs, government entities, and self-insured employers.

CorVel earns service fees through three delivery modes: fully integrated claims-management programs for self-insured employers seeking a single partner, discrete standalone modules for large insurance carriers or TPAs, and targeted add-on services that extend existing client workflows. The bill review platform uses an AI rules engine with over 100 million individual rules to automate claim adjudication and generate savings reports via the CareMC portal. Pharmacy services, directed care networks, case management, and vocational rehabilitation round out the service stack. Competitors include national managed care providers, TPAs, PPOs, and insurance carriers that perform managed care in-house. The Bureau of Labor Statistics reported 2.34 million occupational injuries in 2024, below the pre-pandemic 2019 count of 2.69 million, though CorVel has expanded market share even as total claims volume remains below pre-pandemic levels.

Show full overview

Workers' compensation managed care is subject to state-specific statutes and court decisions that vary extensively across jurisdictions, governing claims handling, benefit amounts, and cost-control strategies. The 10-K identifies legislative reform risk — states have considered but not enacted provisions that would allow employers to designate HMOs or PPOs to cover workers' compensation claimants, which could intensify competition from health plans with existing managed-care capabilities. In May 2026, CorVel disclosed via Form 8-K that Michael Combs, Chairman, CEO, and President for 34 years, will transition to Executive Chair effective July 1, 2026, with Sarah Scott appointed as incoming CEO and President.

See also: Financial Services · Insurance Brokers

From CorVel Corp.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-26
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 20269d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Consecutive earnings misses (4)
Negative momentum
Below 200-MA, MA slope -4.9%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)27.5
P/E (Fwd)
Mkt Cap$3.1B
EV/EBITDA16.2
Profit Mgn11.5%
ROE30.8%
Rev Growth7.4%
Beta0.98
DividendNone
Rating analysts

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

IV46%normal

Material Events(8-K, last 90d)

  • 2026-06-01Item 5.02MEDIUM
    Michael G. Combs (CEO, President, Chairman) transitioning to Executive Chair effective July 1, 2026. Sarah Scott appointed CEO and President effective July 1, 2026. Clean handoff; Combs continues as Executive Chair advising on transition.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Earnings Timing
5.0
Earnings concerns: 0B/4MEarnings in 9 days

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Ma Position
1.0
Volume
1.0
Rsi
3.0
Obv
5.0
Capitulation risk (RSI 28, below 200MA)Below 200-MA, MA slope -4.9%/30d — confirmed downtrend
GatesMomentum 2.0<4.5Death cross (50MA < 200MA)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Executive change: officer departure/appointmentEARNINGS PROXIMITY 9d<=14d (soft)Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Speculative
RSI
28 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $58.49Resistance $66.47

Price Targets

$57
$65
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 2.0 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-04 (9d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CRVL stock a buy right now?

Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $59.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Consecutive earnings misses (4); Negative momentum. Chart setup: Death cross, below all MAs, RSI 28, MACD bearish. Prior stop was $56.74. Score 5.1/10, moderate confidence.

What is the CRVL stock price target?

Take-profit target: $65.14 (+8.8% upside). Prior stop was $56.74. Stop-loss: $56.74.

What are the risks of investing in CRVL?

Consecutive earnings misses (4); Negative momentum; Below 200-MA, MA slope -4.9%/30d (confirmed downtrend).

Is CRVL overvalued or undervalued?

CorVel Corp. trades at a P/E of 27.5 (forward N/A). TrendMatrix value score: 5.1/10. Verdict: Sell.

0
What does CorVel Corp. do?CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill...

CorVel Corporation provides workers' compensation managed care and medical cost containment services — including bill review, PPO network management, utilization management, case management, and pharmacy services — nationwide to insurers, TPAs, and self-insured employers. Revenue is fee-based with no single client exceeding 10% of revenues in fiscal years 2026, 2025, or 2024.

Related stocks: BRO (Brown & Brown, Inc.) · LIFE (Ethos Technologies Inc.) · ARX (Accelerant Holdings) · WTW (Willis Towers Watson Public Lim) · GSHD (Goosehead Insurance, Inc.)
Home Stocks CRVL

Latest news

Latest News

Quiver Quantitative75d agoEarnings
Marketscreener.com75d agoEarnings
Sahm75d agoEarnings
AD HOC NEWS73d ago
Newser.com70d ago
AD HOC NEWS71d agoEarnings
The Chronicle-Journal72d ago
Benzinga39d agoProduct
Benzinga55d agoLeadership Change
Benzinga67d agoEarnings
Benzinga67d agoEarnings
Benzinga67d agoEarnings